000 | 01468 a2200421 4500 | ||
---|---|---|---|
005 | 20250512215106.0 | ||
264 | 0 | _c19841004 | |
008 | 198410s 0 0 eng d | ||
022 | _a0003-9780 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSzentmiklósi, A J | |
245 | 0 | 0 |
_aEffects of hypoxia on the guinea-pig myocardium following inhibition of adenosine deaminase by coformycin. _h[electronic resource] |
260 |
_bArchives internationales de pharmacodynamie et de therapie _cJun 1984 |
||
300 |
_a287-94 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAction Potentials _xdrug effects |
650 | 0 | 4 |
_aAdenosine _xmetabolism |
650 | 0 | 4 | _aAdenosine Deaminase Inhibitors |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCoformycin _xpharmacology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGuinea Pigs |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMembrane Potentials _xdrug effects |
650 | 0 | 4 |
_aMyocardial Contraction _xdrug effects |
650 | 0 | 4 |
_aMyocardium _xmetabolism |
650 | 0 | 4 |
_aNucleoside Deaminases _xantagonists & inhibitors |
650 | 0 | 4 |
_aOxygen _xphysiology |
650 | 0 | 4 |
_aRibonucleosides _xpharmacology |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aNémeth, M | |
700 | 1 | _aCseppentö, A | |
700 | 1 | _aSzegi, J | |
700 | 1 | _aPapp, J G | |
700 | 1 | _aSzekeres, L | |
773 | 0 |
_tArchives internationales de pharmacodynamie et de therapie _gvol. 269 _gno. 2 _gp. 287-94 |
|
999 |
_c6476868 _d6476868 |